A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

Arizona Neuroscience Research, LLC, Pheonix, Arizona, United States

Perseverance Research Center, Scottsdale, Arizona, United States

Regina Berkovich MD, PhD Inc., West Hollywood, California, United States

Nova Clinical Research, LLC, Bradenton, Florida, United States

Neurology Associates, PA, Maitland, Florida, United States

KC Research Center, PA Neurology Research Department, Roeland Park, Kansas, United States

Washington University School of Medicine, St Louis, Missouri, United States

Cooperman Barnabas Medical Center, Livingston, New Jersey, United States

Velocity Clinical Research, Raleigh Neurology, Raleigh, North Carolina, United States

The Boster Center for Multiple Sclerosis, Columbus, Ohio, United States

Premier Neurology, Greenville, South Carolina, United States

Neurology Clinic, P.C., Cordova, Tennessee, United States

Lone Star Neurology, San Antonio, Texas, United States

Texas Institute for Neurological Disorders, Sherman, Texas, United States

Medical Center Nevrocentrum, Plovdiv, Plovdiv, Bulgaria

Diagnostic and Consultative Center Convex, Sofia, Sofia, Bulgaria

Klinicki Bolnicki Centar Zagreb-Rebro, Zagreb, Croatia

NEUROHK, s.r.o., Choceň, Czechia

Astra Clinic (Clinic4U), Tallinn, Harju, Estonia

Neuro Centrum Science Gmbh Albert-Schwitzer, Erbach im Odenwald, Hesse, Germany

IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli, Isemiaa/Molise, Italy

NZOZ Novo Med, Katowice, Silesian Voivodeship, Poland

Nzoz Neuro-Kard Ilkowski I Partnerzy Spolka Partnerska Lekarzy, Poznan, Wielkopolska, Poland

Galen Clinic, Lublin, Poland

NZOZ Neuromed M. i M. Nastaj Sp.P, Lublin, Poland

Nmedis sp.z o.o., Rzeszów, Poland

Hospital Vithas Nisa Sevilla, Castilleja de la Cuesta, Seville, Spain